Published on July 2, 2014
Exhibit 21.1
Subsidiaries of Registrant
Corbus Pharmaceuticals, Inc., a Delaware corporation
Form: DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
July 2, 2014